logo
Share SHARE
FONT-SIZE Plus   Neg

Pre-market Movers For Apr 4-MON, DDIC, MAGS, ZNGA, SNDK, WAG, RYAAY, TSLA, RIMM

Gainers:

Monsanto Co. (MON) is rising more than 1 percent to $83.10. The company's second quarter profit and net sales increased from the previous year. In addition, the company raised its full-year ongoing EPS and free cash flow guidance.

DDi Corp. (DDIC) is gaining 6 percent to $12.98. Viasystems Group Inc. (VIAS) announced that it would acquire the company for $13.00 per share in cash.

Magal Security Systems Ltd. (MAGS) is rising over 23 percent to $5.63. The company swung to a profit in its fourth quarter. Revenues jumped 122.9 percent year-over-year.

Zynga, Inc. (ZNGA) is rising over 2 percent to $12.60. The company announced the completion of public offering of an aggregate of 49.41 million shares of its Class A common stock.

Decliners:

SanDisk Corp. (SNDK) is falling 7 percent to $46.38. The company lowered its revenue guidance for the first quarter of 2012, citing weaker than expected pricing and demand.

Walgreen Co. (WAG) is declining 1 percent to $33.43. he company said comparable store sales and total sales declined 6.8 percent and 4.3 percent, respectively.. The company added that it anticipates that much of its Easter sales will be reflected in April results.

Ryanair Holdings (RYAAY) is falling 3 percent to $35.75. The company's load factor decreased 1 percent, reflecting a 4 percent drop in traffic.

Tesla Motors Inc. (TSLA) is falling more than 6 percent to $35.47.

Research In Motion Limited (RIMM) is falling more than 2 percent to $12.72.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Goldman Sachs downgraded the rating of retailer Target Corp. Thursday to sell from neutral over concerns about its increasing competition with e-commerce giant Amazon.com Inc. Target's price target was reduced to $67 from $77. It is expected that the retailer's efforts to compete with Amazon will result in sluggish sales and profits. Catabasis' phase II trial of Edasalonexent in boys affected by Duchenne muscular dystrophy is ongoing, and top-line results are anticipated in the first half of Q1 2017. American Express Co. (AXP) Thursday reported a drop in fourth-quarter profit, as revenues declined 4 percent due to absence of Costco portfolio while provisions for bad loans and marketing costs increased. Earnings fell short of Wall Street estimates, while revenues trumped expectations. New York-based...
comments powered by Disqus
RELATED NEWS
Trade WAG now with 
Follow RTT